News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
117 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27691)
Month
January (2961)
February (3165)
March (3318)
April (3244)
May (4160)
June (3267)
July (3145)
August (3370)
September (3134)
October (4161)
November (3326)
December (2436)
Day
3 (160)
4 (163)
5 (157)
6 (168)
7 (129)
10 (197)
11 (166)
12 (127)
13 (131)
14 (117)
17 (147)
18 (144)
19 (122)
20 (141)
21 (100)
24 (17)
26 (70)
27 (63)
28 (57)
31 (60)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
26
27
28
31
Policy
FDA Advisory Panel Recommends Against Approval of Merck & Co., Inc.'s NDA for Non-prescription MEVACOR(R) (lovastatin) 20 mg
December 14, 2007
·
3 min read
Drug Development
QRxPharma Pty Ltd. Initiates Second Phase III Clinical Trial for its ‘Dual Opioid’ Pain Therapy
December 14, 2007
·
2 min read
Agendia BV Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen
December 14, 2007
·
3 min read
Kiadis Pharma ATIR Classified as “Cell Based” Medicinal Product by the EMEA A Classification for Innovative New Treatments
December 14, 2007
·
2 min read
Policy
Neurochem, Inc. Announces European Opinion for Eprodisate (KIACTA(TM))
December 14, 2007
·
4 min read
Agendia BV MammaPrint(R) Breast Cancer Test Validated in Lymph Node-Positive Breast Cancer Patients Results to be Presented at San Antonio Breast Cancer Symposium
December 14, 2007
·
3 min read
Business
Pharmaxis Ltd Appoints Portuguese Distributor for Aridol
December 14, 2007
·
2 min read
Business
Isis Pharmaceuticals, Inc. Announces Appointment of B. Lynne Parshall as Chief Operating Officer
December 14, 2007
·
4 min read
Drug Development
Biocryst Pharmaceuticals Data Presented at 2007 American Society of Hematology Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
December 14, 2007
·
5 min read
Business
CellCyte Genetics Corp. Moves Operations From Kirkland to State-Of-The-Art Research Facilities and New Corporate Headquarters in Bothell, Washington
December 14, 2007
·
5 min read
Previous
2 of 12
Next